Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...
India's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report.